Every biologic drug leaves manufacturing with quality data. But once it moves through real-world supply chains and into patients’ homes, that quality becomes invisible.
Beyond Diagnostics is building LUMIQ, a point-of-care medication quality platform that verifies biologic drugs still work in real-world use, starting with insulin, because heat, handling and storage can compromise insulin quality long before patients can detect it.
And as more temperature-sensitive biologics, from GLP-1s to oncology drugs, move into home care, medication quality becomes one of the last unmeasured risks in therapy. LUMIQ creates a new category: real-world medication quality verification for biologics.
We combine rapid strip-based testing, smartphone-based optical readout and AI-supported calibration.
News
Milestones/News
